| 000 | 01856 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513223120.0 | ||
| 264 | 0 | _c20001130 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.2000.18.21.3699 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aElting, L S | |
| 245 | 0 | 0 |
_aTime to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cNov 2000 |
||
| 300 |
_a3699-706 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xeconomics |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFever _xdrug therapy |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLength of Stay _xeconomics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutropenia _xcomplications |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Health Care |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRubenstein, E B | |
| 700 | 1 | _aRolston, K | |
| 700 | 1 | _aCantor, S B | |
| 700 | 1 | _aMartin, C G | |
| 700 | 1 | _aKurtin, D | |
| 700 | 1 | _aRodriguez, S | |
| 700 | 1 | _aLam, T | |
| 700 | 1 | _aKanesan, K | |
| 700 | 1 | _aBodey, G | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 18 _gno. 21 _gp. 3699-706 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2000.18.21.3699 _zAvailable from publisher's website |
| 999 |
_c10997195 _d10997195 |
||